Biotinylated Human HLA-A*02:01&B2M&MAGE-A2 (YLQLVFGIEV) Complex Protein (Monomer, MALS verified)

The MAGE-A2 antigen is a cancer-testis antigen and is expressed intracellularly in various solid tumor tissues, MAGE-A2 157-166 peptide (YLQLVFGIEV) is a cytotoxic T lymphocyte (CTL) epitope presented by HLA-A*0201. The Human HLA-A*0201 MAGE-A2 (YLQLVFGIEV) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, andYLQLVFGIEV peptide of the MAGE-A2.

Biotinylated Human HLA-A*02:01&B2M&MAGE-A2 (YLQLVFGIEV) Complex Protein is produced by co-expression of HLA and B2M loaded with MAGE-A2 peptide. This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™) . The protein has a calculated MW of 36.3 kDa and 11.7 kDa. The protein migrates as 38-44 kDa and 12 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

● -20°C to -70°C for 12 months in lyophilized state; ● -70°C for 3 months under sterile conditions after reconstitution. For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Immobilized Biotinylated Human HLA-A*02:01&B2M&MAGE-A2 (YLQLVFGIEV) Complex Protein (Cat. No. HLM-H82E6) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-HLA class I Antibody, Human IgG1 (W6/32) with a linear range of 0.1-2 ng/mL (QC tested).